Ototoxicity of low- and moderate-dose cisplatin

S. D. Schaefer, J. D. Post, L. G. Close, C. G. Wright

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Twenty-four patients with head and neck neoplasms were prospectively evaluated for cisplatin (DDP)-induced ototoxicity. Patients were selected from a larger population based on the uniformity of their chemotherapy regimen, renal status, lack of prior or concurrent exposure to ototoxic agents, and availability for repetitive audiometric testing in the same setting. Scanning electron microscopy of the inner ear was performed on four temporal bones. Hearing impairment was found to be dose related, irreversible within the confines of the study period, and primarily in the higher frequencies. Vestibular toxicity was rare and well documented by our testing methods in only one patient. Based on the results of this study, and a review of animal and human data on DDP ototoxicity, the authors concluded that ototoxic screening should be reserved for patients defined as 'at risk' and those patients receiving more than 400 mg of DDP under the conditions stated in this report.

Original languageEnglish (US)
Pages (from-to)1934-1939
Number of pages6
JournalCancer
Volume56
Issue number8
StatePublished - 1985

Fingerprint

Cisplatin
Temporal Bone
Inner Ear
Head and Neck Neoplasms
Hearing Loss
Electron Scanning Microscopy
Kidney
Drug Therapy
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Schaefer, S. D., Post, J. D., Close, L. G., & Wright, C. G. (1985). Ototoxicity of low- and moderate-dose cisplatin. Cancer, 56(8), 1934-1939.

Ototoxicity of low- and moderate-dose cisplatin. / Schaefer, S. D.; Post, J. D.; Close, L. G.; Wright, C. G.

In: Cancer, Vol. 56, No. 8, 1985, p. 1934-1939.

Research output: Contribution to journalArticle

Schaefer, SD, Post, JD, Close, LG & Wright, CG 1985, 'Ototoxicity of low- and moderate-dose cisplatin', Cancer, vol. 56, no. 8, pp. 1934-1939.
Schaefer SD, Post JD, Close LG, Wright CG. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 1985;56(8):1934-1939.
Schaefer, S. D. ; Post, J. D. ; Close, L. G. ; Wright, C. G. / Ototoxicity of low- and moderate-dose cisplatin. In: Cancer. 1985 ; Vol. 56, No. 8. pp. 1934-1939.
@article{4fa5256c5d1946e383b90295e121f67e,
title = "Ototoxicity of low- and moderate-dose cisplatin",
abstract = "Twenty-four patients with head and neck neoplasms were prospectively evaluated for cisplatin (DDP)-induced ototoxicity. Patients were selected from a larger population based on the uniformity of their chemotherapy regimen, renal status, lack of prior or concurrent exposure to ototoxic agents, and availability for repetitive audiometric testing in the same setting. Scanning electron microscopy of the inner ear was performed on four temporal bones. Hearing impairment was found to be dose related, irreversible within the confines of the study period, and primarily in the higher frequencies. Vestibular toxicity was rare and well documented by our testing methods in only one patient. Based on the results of this study, and a review of animal and human data on DDP ototoxicity, the authors concluded that ototoxic screening should be reserved for patients defined as 'at risk' and those patients receiving more than 400 mg of DDP under the conditions stated in this report.",
author = "Schaefer, {S. D.} and Post, {J. D.} and Close, {L. G.} and Wright, {C. G.}",
year = "1985",
language = "English (US)",
volume = "56",
pages = "1934--1939",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Ototoxicity of low- and moderate-dose cisplatin

AU - Schaefer, S. D.

AU - Post, J. D.

AU - Close, L. G.

AU - Wright, C. G.

PY - 1985

Y1 - 1985

N2 - Twenty-four patients with head and neck neoplasms were prospectively evaluated for cisplatin (DDP)-induced ototoxicity. Patients were selected from a larger population based on the uniformity of their chemotherapy regimen, renal status, lack of prior or concurrent exposure to ototoxic agents, and availability for repetitive audiometric testing in the same setting. Scanning electron microscopy of the inner ear was performed on four temporal bones. Hearing impairment was found to be dose related, irreversible within the confines of the study period, and primarily in the higher frequencies. Vestibular toxicity was rare and well documented by our testing methods in only one patient. Based on the results of this study, and a review of animal and human data on DDP ototoxicity, the authors concluded that ototoxic screening should be reserved for patients defined as 'at risk' and those patients receiving more than 400 mg of DDP under the conditions stated in this report.

AB - Twenty-four patients with head and neck neoplasms were prospectively evaluated for cisplatin (DDP)-induced ototoxicity. Patients were selected from a larger population based on the uniformity of their chemotherapy regimen, renal status, lack of prior or concurrent exposure to ototoxic agents, and availability for repetitive audiometric testing in the same setting. Scanning electron microscopy of the inner ear was performed on four temporal bones. Hearing impairment was found to be dose related, irreversible within the confines of the study period, and primarily in the higher frequencies. Vestibular toxicity was rare and well documented by our testing methods in only one patient. Based on the results of this study, and a review of animal and human data on DDP ototoxicity, the authors concluded that ototoxic screening should be reserved for patients defined as 'at risk' and those patients receiving more than 400 mg of DDP under the conditions stated in this report.

UR - http://www.scopus.com/inward/record.url?scp=0021930924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021930924&partnerID=8YFLogxK

M3 - Article

C2 - 4040801

AN - SCOPUS:0021930924

VL - 56

SP - 1934

EP - 1939

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -